Drug:
Reaction: GAIT DISTURBANCE
20260101 - 20261231
No. 1501 - 1600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1501 | 26665554 |
US |
86 | 1 |
Hypertension, Rash, Dizziness, Gait disturbance, Hypoacusis, Middle ear effusion, Pain in extremity, Bone pain, Pain, |
||||
LENVATINIB, LENVATINIB, LENVATINIB, |
||||
| 1502 | 26665602 |
EU |
78 | 2 |
Dyspnoea, Arrhythmia, Blood pressure fluctuation, Asthenia, Dizziness, Peripheral swelling, Diarrhoea, Skin plaque, Dyspnoea exertional, Pain in extremity, Gait disturbance, Joint stiffness, Musculoskeletal stiffness, Telangiectasia, Gingival bleeding, |
||||
SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, AMBRISENTAN, TADALAFIL, |
||||
| 1503 | 26665605 |
US |
55 | 2 |
Gait disturbance, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 1504 | 26665645 |
88 | 2 | |
Death, Loss of consciousness, Fracture, Rib fracture, Fall, Pain, Head injury, Hiccups, Headache, Dizziness, Gait disturbance, |
||||
DULOXETINE HYDROCHLORIDE, DULOXETINE, |
||||
| 1505 | 26665724 |
GB |
73 | 2 |
Epistaxis, Amnesia, Gait disturbance, Vomiting, Weight decreased, Injection site bruising, Mobility decreased, Depressed mood, |
||||
EVOLOCUMAB, |
||||
| 1506 | 26665971 |
US |
1 | |
Musculoskeletal stiffness, Movement disorder, Infusion site erythema, Infusion site papule, Mobility decreased, Bradykinesia, Knee deformity, Gait disturbance, Limb deformity, Infusion site discharge, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 1507 | 26678052 |
81 | 2 | |
Back pain, Gait disturbance, Mobility decreased, |
||||
LUSPATERCEPT, |
||||
| 1508 | 26651812 |
US |
2 | |
Gait disturbance, Pain, Product availability issue, |
||||
ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 1509 | 26652151 |
CA |
62 | |
Accident, Body temperature decreased, Road traffic accident, Ear infection, Forced expiratory volume decreased, Gait disturbance, Hip fracture, Hypoacusis, Post procedural complication, Weight decreased, Nasopharyngitis, Injection site induration, Illness, Myalgia, Dizziness, Drug ineffective, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, MOMETASONE FUROATE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ALBUTEROL SULFATE, ALBUTEROL, MONTELUKAST SODIUM, |
||||
| 1510 | 26652225 |
US |
1 | |
Gait disturbance, Malaise, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 1511 | 26652231 |
CA |
57 | 2 |
Dental caries, Temperature intolerance, Balance disorder, Feeling cold, Dry skin, Decreased activity, Gait disturbance, Osteitis, Neck pain, Infection, Multiple sclerosis, Infusion related reaction, Sensory loss, Eye pain, Muscular weakness, Head discomfort, Feeling abnormal, Confusional state, Stress, Burning sensation, Throat irritation, Tooth fracture, Vitamin D decreased, Hypertension, Tremor, Asthenia, Arthralgia, Fatigue, Headache, Drug ineffective, Pruritus, |
||||
PANTOPRAZOLE, OCRELIZUMAB, BACLOFEN, CARBAMAZEPINE, DALFAMPRIDINE, MIRABEGRON, |
||||
| 1512 | 26652385 |
GB |
74 | 1 |
Inappropriate schedule of product administration, Malaise, Confusional state, Neutrophil count abnormal, Fall, Gait disturbance, Gait disturbance, Limb discomfort, Pyrexia, Cerebrovascular accident, Hypoaesthesia, Decreased appetite, Musculoskeletal chest pain, Feeling cold, Chromaturia, Productive cough, |
||||
METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, IXAZOMIB, ACYCLOVIR, ACYCLOVIR, CEPHALEXIN, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, RIVAROXABAN, RIVAROXABAN, RIVAROXABAN, |
||||
| 1513 | 26652405 |
US |
40 | 2 |
Loss of personal independence in daily activities, Drug ineffective, Colitis, Vision blurred, COVID-19, Dysarthria, Hypotension, Migraine, Stress, Vomiting, Pain, Gait disturbance, Panic attack, Crying, Nausea, Asthenia, |
||||
UBROGEPANT, UBROGEPANT, ATOGEPANT, ATOGEPANT, TOPIRAMATE, |
||||
| 1514 | 26652607 |
US |
40 | |
Maternal exposure during pregnancy, Thrombosis, Gait disturbance, |
||||
ENOXAPARIN SODIUM, |
||||
| 1515 | 26652716 |
EU |
72 | |
Psoriatic arthropathy, Pain, Gait disturbance, Hand deformity, Drug ineffective, |
||||
ADALIMUMAB-AATY, ADALIMUMAB-AATY, METHOTREXATE, METHOTREXATE SODIUM, SULFASALAZINE, FOLIC ACID, |
||||
| 1516 | 26652725 |
US |
2 | |
Gait disturbance, Fall, Fatigue, Prescribed underdose, Confusional state, Malaise, |
||||
INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, INTERFERON BETA-1A, |
||||
| 1517 | 26652744 |
EU |
91 | 1 |
Acute kidney injury, Cardiac failure, Cardiac valve disease, Cerebral ischaemia, Pulmonary hypertension, Prostate cancer, Aortic valve stenosis, Infection, Pneumonia, Skin mass, Gait disturbance, Chronic kidney disease, Mitral valve incompetence, Tricuspid valve calcification, Aortic valve stenosis, Atrial fibrillation, Peripheral arterial occlusive disease, Renal artery stenosis, Liver disorder, Hepatic cyst, Cholelithiasis, Rosacea, General physical health deterioration, Blood lactic acid increased, Anaemia, Hyponatraemia, |
||||
EMPAGLIFLOZIN, |
||||
| 1518 | 26653090 |
US |
2 | |
Gastrointestinal haemorrhage, Hypotension, Hip fracture, Nausea, Tachycardia, Blood pressure increased, Chest discomfort, Respiration abnormal, Gait disturbance, Heart rate increased, Headache, Arthralgia, Dizziness, Fatigue, Vomiting, Therapy interrupted, |
||||
ABALOPARATIDE, ABALOPARATIDE, ABALOPARATIDE, ACETAMINOPHEN, ASPIRIN, AND CAFFEINE, IBUPROFEN, |
||||
| 1519 | 26653451 |
74 | ||
Cerebrovascular accident, Gait disturbance, Off label use, |
||||
LENALIDOMIDE, |
||||
| 1520 | 26653551 |
CA |
74 | 1 |
Cardiac failure congestive, Hypertension, Heart rate increased, Dyspnoea, Gait disturbance, Dyspepsia, Asthenia, Decreased appetite, Peripheral swelling, |
||||
RIBOCICLIB, RIBOCICLIB, |
||||
| 1521 | 26653682 |
US |
1 | |
Hallucination, Gait disturbance, Drug ineffective, Product use issue, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 1522 | 26653779 |
US |
88 | 2 |
Gait disturbance, |
||||
SARILUMAB, |
||||
| 1523 | 26653896 |
CA |
43 | 2 |
Porphyria acute, Joint range of motion decreased, Peripheral venous disease, Joint swelling, Adjustment disorder with depressed mood, Muscular weakness, Liver disorder, Anti-cyclic citrullinated peptide antibody positive, Treatment failure, Liver function test increased, Amnesia, C-reactive protein abnormal, Laryngitis, Ulcer haemorrhage, Systemic lupus erythematosus, Pain in extremity, Blister, Wheezing, Sleep disorder, Normal newborn, Alopecia, Product use in unapproved indication, Hypoaesthesia, General physical health deterioration, Grip strength decreased, Dry mouth, Musculoskeletal pain, Asthenia, Abdominal discomfort, Contusion, Condition aggravated, Prescribed underdose, Hepatic enzyme increased, Pericarditis, Arthropathy, Adverse drug reaction, Lip dry, Incorrect route of product administration, Pancreatitis, Rheumatic fever, Chest pain, White blood cell count increased, Off label use, Taste disorder, Gait disturbance, Lupus-like syndrome, Facet joint syndrome, Impaired healing, Swollen joint count increased, Red blood cell sedimentation rate increased, Autoimmune disorder, Rectal haemorrhage, Arthralgia, Underdose, Bone erosion, Sciatica, Injection site reaction, Intentional product use issue, Blood cholesterol increased, Epilepsy, Product use issue, Liver injury, Peripheral swelling, Night sweats, Exostosis, Muscle injury, Vomiting, Synovitis, Psoriatic arthropathy, Hypercholesterolaemia, Nail disorder, Abdominal pain upper, Fibromyalgia, Rash, Bursitis, Osteoarthritis, Fatigue, Confusional state, Breast cancer stage II, Asthma, Intentional product misuse, Live birth, Gait inability, Dyspepsia, Back injury, Therapy non-responder, Inflammation, Lung disorder, Onychomadesis, Paraesthesia, Ear pain, Pain, Deep vein thrombosis postoperative, Irritable bowel syndrome, Abdominal pain, Drug intolerance, Wound infection, Frequent bowel movements, Wound, Migraine, Neck pain, Drug hypersensitivity, Memory impairment, Infusion related reaction, Weight increased, Muscle spasms, Ill-defined disorder, Rheumatoid arthritis, Laboratory test abnormal, Oedema peripheral, Folliculitis, Overlap syndrome, Blepharospasm, Product quality issue, Therapeutic product effect decreased, Swelling, Type 2 diabetes mellitus, Urticaria, Anxiety, Helicobacter infection, Drug ineffective, Pneumonia, Dizziness, Depression, Injury, Diarrhoea, Contraindicated product administered, Glossodynia, X-ray abnormal, Gastrooesophageal reflux disease, Maternal exposure during pregnancy, Hypertension, Stomatitis, Feeling hot, Nasopharyngitis, Pemphigus, Sinusitis, Infusion site reaction, Mobility decreased, Breast cancer stage III, Discomfort, Road traffic accident, Duodenal ulcer perforation, Lower limb fracture, Therapeutic product effect incomplete, Hand deformity, Respiratory disorder, Onychomycosis, Lower respiratory tract infection, Obesity, Adverse event, |
||||
BUPRENORPHINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, ERENUMAB-AOOE, LEFLUNOMIDE, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, CELECOXIB, CELECOXIB, LAMOTRIGINE, LAMOTRIGINE, BUPRENORPHINE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, AZATHIOPRINE, CELECOXIB, APREMILAST, APREMILAST, APREMILAST, BOTULINUM TOXIN TYPE A, CANDESARTAN, MEPOLIZUMAB, ATOMOXETINE, RISEDRONATE SODIUM, LISINOPRIL, QUETIAPINE FUMARATE, QUETIAPINE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, LANSOPRAZOLE, SULFASALAZINE, FISH OIL, |
||||
| 1524 | 26653931 |
CA |
40 | 1 |
Pain in extremity, Tendon pain, Gait disturbance, Arthralgia, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, |
||||
| 1525 | 26654566 |
US |
87 | 2 |
Deep vein thrombosis, Ophthalmoplegia, Muscular weakness, Hypoaesthesia, Blood pressure increased, Myopathy, Gait disturbance, Post herpetic neuralgia, Fatigue, Asthenia, Osteoarthritis, Gastrooesophageal reflux disease, |
||||
ECULIZUMAB, EPINEPHRINE, ADRENALINUM, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, PANTOPRAZOLE SODIUM, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, GLYCOPYRROLATE, CALCIUM, PREDNISONE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, AMLODIPINE BESYLATE, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, AMLODIPINE BESYLATE, CALCIUM CARBONATE, ANTACID, FERROUS SULFATE, PYRIDOSTIGMINE BROMIDE, |
||||
| 1526 | 26654747 |
US |
79 | 2 |
Thymic carcinoma, Gait disturbance, Loss of personal independence in daily activities, Weight decreased, Ageusia, On and off phenomenon, Fall, Malnutrition, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, SOLIFENACIN SUCCIATE, SOLIFENACIN SUCCINATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CERTOLIZUMAB PEGOL, OXYCODONE HYDROCHLORIDE, OXYCODONE, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, ERGOCALCIFEROL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN, DEXTROMETHORPHAN, ACETAMINOPHEN AND DEXTROMETHORPHAN HYDROBROMIDE, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, SODIUM CHLORIDE, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE TABLETS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, METHOCARBAMOL, METHOCARBAMOL TABLETS, SERTRALINE HYDROCHLORIDE, |
||||
| 1527 | 26655025 |
US |
2 | |
Hip fracture, Gait disturbance, |
||||
| 1528 | 26655346 |
US |
1 | |
Arthralgia, Myalgia, Gait disturbance, Drug ineffective, |
||||
DUPILUMAB, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, FAMOTIDINE, FLUTICASONE PROPIONATE, LISINOPRIL, MAGNESIUM, MAGNESIUM, MONTELUKAST SODIUM, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE INHALATION SPRAY, CETIRIZINE HYDROCHLORIDE, LOSARTAN POTASSIUM, LOSARTAN, CETIRIZINE HCL, CETIRIZINE, FAMOTIDINE, TEZEPELUMAB-EKKO, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, AZELASTINE HYDROCHLORIDE, AZELASTINE, ALBUTEROL SULFATE, PREDNISONE, |
||||
| 1529 | 26655366 |
US |
59 | 2 |
Intervertebral disc disorder, Muscle spasms, Gait disturbance, Pain, Device fastener issue, Spinal fracture, |
||||
RISANKIZUMAB-RZAA, |
||||
| 1530 | 26655501 |
US |
55 | 1 |
Pain, Gait disturbance, |
||||
SARILUMAB, |
||||
| 1531 | 26655525 |
US |
72 | 1 |
Blood sodium increased, Confusional state, Dizziness, Gait disturbance, Dyskinesia, Blood magnesium decreased, Asthenia, Lethargy, Headache, Blood pressure increased, |
||||
LECANEMAB, CLOPIDOGREL, |
||||
| 1532 | 26655569 |
CA |
82 | 1 |
Chills, Wheezing, Gait disturbance, Respiratory rate increased, |
||||
BELANTAMAB MAFODOTIN, |
||||
| 1533 | 26655704 |
US |
58 | 2 |
Blepharospasm, Alopecia, Gait disturbance, Headache, Off label use, |
||||
SOLRIAMFETOL, SOLRIAMFETOL, |
||||
| 1534 | 26655867 |
US |
72 | 1 |
Hypertension, Blood pressure fluctuation, Gait disturbance, Asthenia, Mobility decreased, Hallucination, Insomnia, Musculoskeletal stiffness, Dyskinesia, Fall, Muscular weakness, Tremor, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, ALLOPURINOL, MIDODRINE HYDROCHLORIDE, ROSUVASTATIN, CALCIUM, MELATONIN, POLYETHYLENE GLYCOL 3350, RIVASTIGMINE TARTRATE, DOCUSATE SODIUM, |
||||
| 1535 | 26655917 |
US |
37 | 1 |
Fatigue, Gait disturbance, Neck pain, |
||||
DORDAVIPRONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, PANTOPRAZOLE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, |
||||
| 1536 | 26669691 |
65 | 2 | |
Paraesthesia, Muscle disorder, Pain, Arthralgia, Cardiac disorder, Gait disturbance, Muscular weakness, |
||||
METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA, VALSARTAN, VALSARTAN ORAL, SODIUM ZIRCONIUM CYCLOSILICATE, TORSEMIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, BLACK COHOSH, BRYONIA ALBA WHOLE, TOXICODENDRON PUBESCENS WHOLE, ARNICA MONTANA, CAUSTICUM, FERROSOFERRIC PHOSPHATE, SODIUM SULFATE ANHYDROUS, STRYCHNOS NUX-VOMICA SEED, RHODODENDRON AUREUM WHOLE, CITRULLUS COLOCYNTHIS WHOLE, SOLANUM DULCAMARA WHOLE, KALMIA LATIFOLIA WHOLE, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, ARSENIC TRIOXIDE, AND TRIBASIC CALCIUM PHOSPHATE, BERBERIS VULGARIS ROOT BARK, BRYONIA ALBA ROOT, PHENOL, MILK THISTLE, CHELIDONIUM MAJUS, JUNIPER BERRY, LYCOPODIUM CLAVATUM SPORE, SODIUM PHOSPHATE, DIBASIC, HEPTAHYDRATE, SODIUM SULFATE, STRYCHNOS NUX-VOMICA SEED, PHOSPHORUS, LACTIC ACID, L-, TARAXACUM OFFICINALE, VISCUM ALBUM FRUITING TOP, AND YUCCA FILAMENTOSA, ARTEMISIA CINA PRE-FLOWERING TOP, TANACETUM VULGARE WHOLE, ARTEMISIA VULGARIS WHOLE, DRYOPTERIS FILIX-MAS ROOT, MERCURIC CHLORIDE, AND GRAPHITE, AMBROSIA ARTEMISIAEFOLIA, ARALIA RACEMOSA, ARNICA MONTANA, CALENDULA OFFICINALIS, CHROMICUM ACIDUM, ECHINACEA PURPUREA, EUCALYPTOL, KALI BICHROMICUM, KALI MURIATICUM, KALI SULPHURICUM, LAC VACCINUM, MERCURIUS IODATUS FLAVUS, MERCURIUS SULPHURATUS RUBER, NATRUM ARSENICICUM, ROSA DAMASCENA, SABADILLA, SANGUINARINUM NITRICUM, SYMPHYTUM OFFICINALE, NAJA NAJA WHOLE, SCROPHULARIA NODOSA, LACTIC ACID, DL-, AND RADIUM BROMIDE, APIS MELLIFERA, ASPARAGUS, BERBERIS VULGARIS ROOT BARK, LYTTA VESICATORIA, CHELIDONIUM MAJUS, JUNIPER BERRY, MAGNESIUM CHLORIDE, SODIUM CHLORIDE, POPULUS TREMULOIDES BARK, RHUS AROMATICA ROOT BARK, RUBIA TINCTORUM ROOT, SAW PALMETTO, SOLIDAGO VIRGAUREA FLOWERING TOP, TARAXACUM OFFICINALE, AND ARCTOSTAPHYLOS UVA-URSI LEAF, ZINCUM VALERIANICUM, IGNATIA AMARA, CHAMOMILLA VULGARIS, COFFEA CRUDA, KALI BROMATUM, ESCHSCHOLTZIA CALIFORNICA, HUMULUS LUPULUS, PASSIFLORA INCARNATA, VALERIANA OFFICINALIS, AVENA SATIVA, APIS MELLIFICA, ARGENTUM NITRICUM, BADIAGA, BELLADONNA, CANTHARIS, CAUSTICUM, CHIMAPHILA UMBELLATA, COLOCYNTHIS, CUBEBA OFFICINALIS, CUCURBITA CITRULLUS, CUCURBITA PEPO FLOWER, ECHINACEA ANGUSTIFOLIA, EQUISETUM HYEMALE, ERYNGIUM AQUATICUM, FERRUM PHOSPHORICUM, MITCHELLA REPENS, OLEUM SANTALI, PETROSELINUM SATIVUM, PIPER METHYSTICUM, POPULUS TREMULOIDES BARK, SARSAPARILLA, TEREBINTHINA, UVA URSI, ACHILLEA MILLEFOLIUM, ARNICA MONTANA, HYPERICUM PERFORATUM, HORSE CHESTNUT, AND VISCUM ALBUM WHOLE, ACONITUM NAPELLUS, AMERICAN GINSENG, ARSENICUM IODATUM, BLATTA ORIENTALIS, CALCAREA SULPHURICA, CARPINUS BETULUS FLOWER, CUPRUM METALLICUM, GRINDELIA, HEPAR SULPHURIS CALCAREUM, IPECACUANHA, JUSTICIA ADHATODA, KALI IODATUM, LOBELIA INFLATA, NAPHTHALINUM, NARCISSUS PSEUDONARCISSUS, PINE TAR, POPULUS CANDICANS, TABACUM, THUJA OCCIDENTALIS, THYMUS SERPYLLUM, PASSIFLORA INCARNATA WHOLE, SMILAX ORNATA WHOLE, PHYTOLACCA AMERICANA ROOT, STILLINGIA SYLVATICA ROOT, TRIFOLIUM PRATENSE WHOLE, ARCTIUM LAPPA WHOLE, PRUNUS DULCIS WHOLE, FRANGULA PURSHIANA BARK, BERBERIS VULGARIS WHOLE, GLYCYRRHIZA GLABRA WHOLE, AND LARREA DIVARICATA WHOLE, ALOE, ACTIVATED CHARCOAL, COLCHICUM AUTUMNALE BULB, COLLINSONIA CANADENSIS ROOT, CUCURBITA PEPO FLOWER, DRYOPTERIS FILIX-MAS ROOT, INDOLE, SKIM MILK, LYCOPODIUM CLAVATUM SPORE, ACHILLEA MILLEFOLIUM, SODIUM SULFATE, FRANGULA PURSHIANA BARK, SCROPHULARIA NODOSA, SKATOLE, TARAXACUM OFFICINALE, TARTARIC ACID, ARANEUS DIADEMATUS, ARISAEMA TRIPHYLLUM ROOT, ASTERIAS RUBENS, BAPTISIA TINCTORIA, BARIUM IODIDE, ECHINACEA ANGUSTIFOLIA, FERROUS IODIDE, GOLDENSEAL, LACHESIS MUTA VENOM, PHYTOLACCA AMERICANA ROOT, PINUS SYLVESTRIS FLOWERING TOP, SCROPHULARIA NODOSA, SPONGIA OFFICINALIS SKELETON, ROASTED, AND TEUCRIUM SCORODONIA FLOWERING TOP, ALFALFA, ALLIUM SATIVUM, ASPARAGUS OFFICINALIS, AVENA SATIVA, BELLADONNA, BERBERIS VULGARIS, CHELIDONIUM MAJUS, GLYCYRRHIZA GLABRA, HYDRASTIS CANADENSIS, JUNIPERUS VIRGINIANA, NICCOLUM METALLICUM, PASSIFLORA INCARNATA, SARCOLACTICUM ACIDUM, SOLIDAGO VIRGAUREA, TARAXACUM OFFICINALE, ALNUS GLUTINOSA, APIS MELLIFICA, BERBERIS VULGARIS, CALCIUM SULFIDE, CROTON TIGLIUM, ECHINACEA ANGUSTIFOLIA, GRAPHITE, GRINDELIA HIRSUTULA, HYDROFLUORIC ACID, JUGLANS REGIA, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, MYRISTICA SEBIFERA, NITRICUM ACIDUM, PHOSPHORUS, RHUS TOXICODENDRON, SCROPHULARIA NODOSA, SOLIDAGO VIRGAUREA, SULPHUR, VINCA MINOR, |
||||
| 1537 | 26670017 |
35 | 1 | |
Pain, Muscle spasms, Gait disturbance, Injection site pain, |
||||
LENACAPAVIR SODIUM, ROSUVASTATIN, TADALAFIL, ZOLPIDEM TARTRATE, FISH OIL, ERGOCALCIFEROL, |
||||
| 1538 | 26646117 |
CA |
71 | 2 |
Increased tendency to bruise, Laboratory test abnormal, Open angle glaucoma, Fatigue, Gait disturbance, |
||||
DIPHENHYDRAMINE HYDROCHLORIDE, MOMETASONE FUROATE, |
||||
| 1539 | 26646320 |
US |
2 | |
Inflammation, Gait disturbance, Pain, Swelling, Asthenia, Hypoaesthesia, |
||||
ZOLEDRONIC ACID, |
||||
| 1540 | 26646340 |
EU |
40 | 1 |
Gait disturbance, Myalgia, Fatigue, Muscle spasms, Musculoskeletal stiffness, |
||||
ROSUVASTATIN, |
||||
| 1541 | 26646388 |
US |
2 | |
Gait disturbance, Urinary incontinence, Peripheral swelling, |
||||
DAPAGLIFLOZIN, |
||||
| 1542 | 26646425 |
JP |
70 | 1 |
Dyspnoea, COVID-19, Dyspnoea, Thirst, Condition aggravated, Diarrhoea, Faeces soft, Faeces hard, Muscle strength abnormal, Gait disturbance, |
||||
NINTEDANIB, NINTEDANIB, |
||||
| 1543 | 26646512 |
BR |
69 | 1 |
Colorectal cancer metastatic, Dizziness, Skin burning sensation, Dermal cyst, Dermatitis allergic, Sensitive skin, Hypoaesthesia, Skin irritation, Myalgia, Skin atrophy, Pain of skin, Gait disturbance, Pain in extremity, Somnolence, Limb injury, Skin wound, Skin discolouration, Head discomfort, Ocular hyperaemia, Pruritus, Asthenia, Rash macular, Nausea, Skin exfoliation, Vomiting, Erythema, Skin fissures, Stomatitis, Gastrointestinal pain, Malaise, Constipation, Influenza like illness, Anxiety, Pain, Oropharyngeal pain, Headache, Tension, Skin lesion, Face injury, Vessel puncture site pain, Dry skin, Tooth disorder, Scratch, Asthenia, |
||||
PANITUMUMAB, PANITUMUMAB, PANITUMUMAB, PANITUMUMAB, AMLODIPINE BESYLATE, GABAPENTIN, DIMENHYDRINATE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, LOSARTAN POTASSIUM, LOSARTAN, DOXYCYCLINE, DOXYCYCLINE HYCLATE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LACTULOSE, LOSARTAN, AMLODIPINE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM, LOSARTAN, |
||||
| 1544 | 26646589 |
US |
55 | |
Meningitis, Therapy interrupted, Product use issue, Gait disturbance, Condition aggravated, Fatigue, Anaemia, Product dose omission issue, |
||||
| 1545 | 26646617 |
US |
2 | |
Gait disturbance, |
||||
DONANEMAB-AZBT, |
||||
| 1546 | 26646740 |
US |
76 | 2 |
Gait disturbance, Loss of personal independence in daily activities, Neck pain, Pain, Drug ineffective, Psoriasis, |
||||
APREMILAST, APREMILAST, LORATADINE, LORATADINE TABLET, IRON, MAGNESIUM, |
||||
| 1547 | 26646865 |
CA |
62 | 2 |
Asthma, Bone pain, Bronchitis, Seizure, Sleep disorder due to a general medical condition, Chest discomfort, Chronic obstructive pulmonary disease, Drug dependence, Dyspnoea, Exercise tolerance decreased, Full blood count abnormal, Gait disturbance, Heart rate increased, Illness, Joint swelling, Loss of personal independence in daily activities, Lung adenocarcinoma stage IV, Metastases to central nervous system, Pneumothorax, Steroid dependence, Wheezing, Malaise, Product complaint, Therapeutic product effect incomplete, |
||||
RISEDRONATE SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ALBUTEROL SULFATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, BUDESONIDE, BUDESONIDE, BUDESONIDE, CALCIUM CARBONATE, ANTACID, MEPOLIZUMAB, OXYGEN, 0XYGEN, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ERGOCALCIFEROL, |
||||
| 1548 | 26647149 |
GB |
74 | 1 |
Inappropriate schedule of product administration, Cerebrovascular accident, Hypoaesthesia, Balance disorder, Confusional state, Fall, Malaise, Limb discomfort, Gait disturbance, Musculoskeletal chest pain, Productive cough, Feeling cold, Chromaturia, Pyrexia, Decreased appetite, Neutrophil count abnormal, |
||||
ACYCLOVIR, ACYCLOVIR, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, IXAZOMIB, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, RIVAROXABAN, RIVAROXABAN, RIVAROXABAN, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, CEPHALEXIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 1549 | 26647337 |
US |
23 | 2 |
Mental impairment, Diarrhoea, Pain, Chills, Nausea, Discomfort, Gait disturbance, Crying, Somnolence, Sedation, Anxiety, Bradykinesia, Syncope, Headache, Asthenia, Gastrointestinal infection, |
||||
ZURANOLONE, ZURANOLONE, |
||||
| 1550 | 26647775 |
US |
72 | 2 |
Ankle fracture, Lower limb fracture, Pain, Gait disturbance, |
||||
RISANKIZUMAB-RZAA, OXYCODONE, |
||||
| 1551 | 26648360 |
EU |
23 | 2 |
Epilepsy, Gait disturbance, Movement disorder, |
||||
LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 1552 | 26648605 |
US |
87 | 2 |
Asthenia, Gait disturbance, Fatigue, Product dose omission issue, |
||||
DUPILUMAB, FEXOFENADINE HYDROCHLORIDE, CALCIUM, CINNAMON, ERGOCALCIFEROL, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, HYDROXYZINE, LEVALBUTEROL, LEVALBUTEROL HYDROCHLORIDE, MAGNESIUM, MONTELUKAST, NIACIN, ROSUVASTATIN, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VITAMIN C, |
||||
| 1553 | 26648938 |
US |
70 | 2 |
Death, Thrombosis, Feeding disorder, Gait disturbance, Quality of life decreased, Cheilitis, Diarrhoea, Constipation, Stomatitis, Gingival bleeding, Dizziness, |
||||
CABOZANTINIB, |
||||
| 1554 | 26649128 |
GB |
1 | |
Malaise, Gait disturbance, Pneumonia, Confusional state, C-reactive protein increased, |
||||
CLOZAPINE, |
||||
| 1555 | 26649584 |
US |
70 | 2 |
Gait disturbance, Sarcopenia, Musculoskeletal pain, Asthenia, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 1556 | 26649713 |
TW |
66 | 2 |
Fall, Gait disturbance, Inflammatory marker increased, Liver function test increased, Underweight, Neoplasm progression, Fatigue, Vomiting, Decreased appetite, Tremor, Pyrexia, |
||||
TRAMETINIB, DABRAFENIB, |
||||
| 1557 | 26649718 |
US |
84 | 2 |
Gait disturbance, Recalled product administered, Fall, |
||||
METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 1558 | 26649889 |
US |
||
Blood glucose fluctuation, Product substitution issue, Gait disturbance, Therapeutic response changed, Tremor, Dizziness, Asthenia, |
||||
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, |
||||
| 1559 | 26650146 |
CA |
52 | 1 |
Metastases to bone, Arthralgia, Gait disturbance, Herpes zoster, Joint swelling, Post herpetic neuralgia, |
||||
TOFACITINIB, DAROLUTAMIDE, |
||||
| 1560 | 26650432 |
CN |
86 | 2 |
Gait disturbance, Muscular weakness, Body temperature abnormal, |
||||
ZOLEDRONIC ACID, |
||||
| 1561 | 26650710 |
US |
83 | |
Back disorder, Gait disturbance, Constipation, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 1562 | 26650855 |
2 | ||
Fatigue, Asthenia, Pelvic abscess, Bacterial infection, Toxicity to various agents, Lung abscess, Motor dysfunction, Ataxia, Gait disturbance, Decubitus ulcer, |
||||
CLOZAPINE, CLOZAPINE, CLOZAPINE, CLOZAPINE, LORAZEPAM, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LANSOPRAZOLE, APIXABAN, |
||||
| 1563 | 26651385 |
EU |
75 | 2 |
Cardiac disorder, Dyskinesia, Freezing phenomenon, Fear of falling, Gait disturbance, Depressed mood, Hallucination, Adverse drug reaction, On and off phenomenon, Emotional distress, Anxiety, Stoma site hypergranulation, Stoma site discharge, |
||||
| 1564 | 26651405 |
US |
70 | 2 |
General physical health deterioration, Weight decreased, Feeding disorder, Blindness, Gait disturbance, Off label use, Eye infection, Renal disorder, Pathogen resistance, |
||||
TEPROTUMUMAB, TEPROTUMUMAB, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, |
||||
| 1565 | 26651503 |
US |
2 | |
Pain in extremity, Gait disturbance, |
||||
DIROXIMEL FUMARATE, |
||||
| 1566 | 26651546 |
EU |
77 | 1 |
Hyperthermia, Urinary incontinence, Asthenia, Cognitive disorder, Dysarthria, Feeling abnormal, Tremor, Dysphagia, Cough, Loss of personal independence in daily activities, Nausea, Pain in extremity, Mood swings, Anxiety, On and off phenomenon, Gait disturbance, Anal incontinence, Muscle rigidity, Dyskinesia, Hypotension, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 1567 | 26661720 |
67 | 2 | |
Gait disturbance, Arthralgia, Muscle spasms, |
||||
PITAVASTATIN CALCIUM, BRIMONIDINE TARTRATE, TIMOLOL MALEATE, LATANOPROSTENE BUNOD, DORZOLAMIDE, ALBUTEROL SULFATE, ALBUTEROL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, |
||||
| 1568 | 26640139 |
EU |
75 | 1 |
Cataract, Muscular weakness, Weight decreased, Abnormal dreams, Memory impairment, Bradyphrenia, Hallucination, Stoma site erythema, Tension, Dyskinesia, On and off phenomenon, Restlessness, Stoma site discharge, Pain, Movement disorder, Compulsions, Mobility decreased, Gait disturbance, Loss of personal independence in daily activities, Therapeutic product effect incomplete, |
||||
CLOZAPINE, CLONAZEPAM, RIVASTIGMINE, |
||||
| 1569 | 26640160 |
CO |
75 | 2 |
Pneumonia, Gait disturbance, Depression, Candida infection, |
||||
EVOLOCUMAB, EVOLOCUMAB, |
||||
| 1570 | 26640547 |
JP |
2 | |
Cartilage injury, Arthralgia, Hernia, Osteoporosis, Muscular weakness, Foot deformity, Musculoskeletal stiffness, Peripheral swelling, Gait disturbance, Bone density decreased, Laboratory test abnormal, Mood swings, Emotional distress, Blood pressure abnormal, Hypoaesthesia, Oedema peripheral, |
||||
ZOLEDRONIC ACID, ZOLEDRONIC ACID, ZOLEDRONIC ACID, RALOXIFENE HYDROCHLORIDE, RALOXIFENE, |
||||
| 1571 | 26640555 |
CA |
58 | 2 |
Cardiac flutter, Pain in extremity, Sleep deficit, Malaise, Dyspepsia, Diarrhoea, Fatigue, Dyspnoea, Palpitations, Impaired quality of life, Arthralgia, Gait disturbance, Impaired work ability, Loss of personal independence in daily activities, Chest discomfort, |
||||
INFLIXIMAB, |
||||
| 1572 | 26640772 |
US |
1 | |
Hallucination, Sleep disorder, Constipation, Confusional state, Gait disturbance, Oedema peripheral, Product dose omission issue, |
||||
PIMAVANSERIN TARTRATE, RASAGILINE MESYLATE, ENTACAPONE, FERROUS SULFATE, AMANTADINE, MAGNESIUM, RASAGILINE MESYLATE, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 1573 | 26640840 |
US |
69 | 2 |
Systemic lupus erythematosus, Therapy interrupted, Gait disturbance, |
||||
ETANERCEPT, |
||||
| 1574 | 26640952 |
CA |
43 | 2 |
Abdominal discomfort, Abdominal pain, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Dyspnoea, Arthralgia, Arthropathy, Asthenia, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, Condition aggravated, Decreased appetite, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Drug hypersensitivity, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Ear pain, Fatigue, Fibromyalgia, Gait disturbance, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Helicobacter infection, Hepatic enzyme increased, Hypertension, Hypoaesthesia, Intentional product use issue, Joint range of motion decreased, Maternal exposure during pregnancy, Pemphigus, Pericarditis, Rash, Swelling, Synovitis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Vomiting, Wheezing, Wound, Wound infection, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
| 1575 | 26641386 |
CN |
45 | 1 |
Joint stiffness, Hypokinesia, Joint swelling, Gait disturbance, Intermittent claudication, |
||||
| 1576 | 26641523 |
74 | 1 | |
Cerebrovascular accident, Inappropriate schedule of product administration, Balance disorder, Chromaturia, Fall, Gait disturbance, Hypoaesthesia, Limb discomfort, Musculoskeletal chest pain, Neutrophil count abnormal, Productive cough, Malaise, Decreased appetite, Feeling cold, Pyrexia, Confusional state, |
||||
CEPHALEXIN, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ACYCLOVIR, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, IXAZOMIB, LENALIDOMIDE, RIVAROXABAN, |
||||
| 1577 | 26641869 |
US |
74 | 1 |
Nightmare, Walking aid user, Tremor, Gait disturbance, Fall, Drug ineffective, |
||||
PIMAVANSERIN TARTRATE, PIMAVANSERIN TARTRATE, QUETIAPINE, BUPROPION HYDROCHLORIDE, CLONAZEPAM, RIVASTIGMINE, |
||||
| 1578 | 26641955 |
CA |
43 | 2 |
Confusional state, Contraindicated product administered, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Drug intolerance, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Facet joint syndrome, Gait disturbance, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Grip strength decreased, Off label use, Overdose, |
||||
TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 1579 | 26642143 |
US |
2 | |
Muscle disorder, Gait disturbance, Skin swelling, |
||||
DUPILUMAB, NEMOLIZUMAB-ILTO, |
||||
| 1580 | 26643104 |
US |
2 | |
Spinal column injury, Arthritis, Gait disturbance, Fall, |
||||
ORAL SEMAGLUTIDE, |
||||
| 1581 | 26643523 |
IN |
76 | 1 |
Blood pressure increased, Rash, Pruritus, Anxiety, Malaise, Eye disorder, Pain in extremity, Localised infection, Furuncle, Burning sensation, Gait disturbance, |
||||
DACOMITINIB, |
||||
| 1582 | 26643621 |
US |
64 | 2 |
Gait disturbance, Inappropriate schedule of product administration, |
||||
INSULIN GLARGINE, LIRAGLUTIDE, |
||||
| 1583 | 26643927 |
CO |
76 | 2 |
Spinal cord infection, Large intestinal ulcer, Colitis, Gastrointestinal inflammation, Jaundice, COVID-19, Optic neuritis, Ear disorder, Hiatus hernia, Ill-defined disorder, Off label use, Fall, Joint injury, Hepatic steatosis, Limb injury, Nail avulsion, Osteoarthritis, Gait disturbance, Amnesia, Pain, Stress, Melanocytic naevus, Pruritus, Scratch, Wound, Dry skin, Meibomian gland dysfunction, Hair disorder, |
||||
ROMOSOZUMAB-AQQG, |
||||
| 1584 | 26644531 |
GB |
3 | 2 |
Suicide attempt, Slow speech, Dysphemia, Gait disturbance, Cogwheel rigidity, Musculoskeletal stiffness, Tremor, |
||||
VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, |
||||
| 1585 | 26644692 |
CA |
66 | 2 |
Forced expiratory volume decreased, Product dose omission issue, Arthralgia, Malaise, Bronchitis, Epistaxis, Cardiac failure, Blood immunoglobulin E increased, Chest discomfort, Condition aggravated, Restrictive pulmonary disease, Cough, Pulmonary thrombosis, Device allergy, Forced vital capacity decreased, Drug hypersensitivity, Inspiratory capacity decreased, Dysphonia, Middle insomnia, Dyspnoea, Dyspnoea exertional, Asthenia, Dysstasia, Fall, Feeling abnormal, Forced expiratory flow decreased, Forced vital capacity increased, Gait disturbance, Gastroenteritis viral, General physical health deterioration, Hyperglycaemia, Illness, Infection susceptibility increased, Insomnia, Joint injury, Joint swelling, Lethargy, Limb injury, Lower respiratory tract infection, Lung diffusion test decreased, Lung disorder, Asthma, Muscular weakness, Nasal mucosal disorder, Nasal obstruction, Obesity, Obstructive airways disorder, Oropharyngeal pain, Oxygen saturation decreased, Pain in extremity, Palpitations, Pleural effusion, Back pain, Pulmonary embolism, Respiratory distress, Respiratory rate decreased, Sciatica, Secretion discharge, Sinusitis, Swelling face, Viral upper respiratory tract infection, Vomiting, Weight decreased, Wheezing, Blood glucose increased, Blood iron decreased, Blood pressure increased, |
||||
PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, ROFLUMILAST, RIVAROXABAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, TRIMETHOPRIM, MONTELUKAST SODIUM, AMLODIPINE BESYLATE, TIOTROPIUM BROMIDE, SIMVASTATIN, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN HYDROCHLORIDE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CICLESONIDE, |
||||
| 1586 | 26644731 |
US |
77 | 2 |
Dysstasia, Fall, Complication associated with device, Renal disorder, Pancreatic disorder, Blood glucose increased, Gait disturbance, Heart rate decreased, Hypertension, Arrhythmia, Encephalitis herpes, Clostridium difficile infection, Mobility decreased, Feeling abnormal, Off label use, Diarrhoea, Alopecia, |
||||
ABEMACICLIB, LETROZOLE, LETROZOLE TABLETS, ENALAPRIL, TORSEMIDE, |
||||
| 1587 | 26644812 |
86 | ||
Heart rate increased, Hypotension, Pain, Oxygen saturation decreased, Nausea, Dyspnoea, Diarrhoea, Asthenia, Hair growth abnormal, Gastric pH decreased, Tremor, Feeling cold, Feeling abnormal, Eating disorder, Gait disturbance, Diarrhoea, Constipation, |
||||
ELACESTRANT, ELACESTRANT, ELACESTRANT, EVEROLIMUS, EVEROLIMUS TABLETS, |
||||
| 1588 | 26645402 |
US |
89 | 1 |
Arthralgia, Gait disturbance, |
||||
| 1589 | 26645935 |
US |
1 | |
Swelling, Gait disturbance, Limb discomfort, Decreased appetite, Abdominal pain, Hernia, Fatigue, Bedridden, |
||||
OLAPARIB, |
||||
| 1590 | 26639501 |
GB |
3 | 2 |
Suicide attempt, Slow speech, Dysphemia, Gait disturbance, Cogwheel rigidity, Musculoskeletal stiffness, Tremor, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 1591 | 26639516 |
GB |
74 | 1 |
Inappropriate schedule of product administration, Cerebrovascular accident, Hypoaesthesia, Balance disorder, Confusional state, Fall, Malaise, Limb discomfort, Gait disturbance, Musculoskeletal chest pain, Productive cough, Feeling cold, Chromaturia, Pyrexia, Decreased appetite, Neutrophil count abnormal, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ACYCLOVIR, ACYCLOVIR, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, IXAZOMIB, LENALIDOMIDE, LENALIDOMIDE, LENALIDOMIDE, RIVAROXABAN, RIVAROXABAN, RIVAROXABAN, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HCL, LOPERAMIDE HYDROCHLORIDE ORAL, CEPHALEXIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 1592 | 26639540 |
US |
63 | 2 |
Partial seizures, Orthopaedic procedure, Respiratory distress, Migraine without aura, Occipital neuralgia, Tremor, Gait disturbance, Hyperparathyroidism, |
||||
DENOSUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICYCLOMINE HYDROCHLORIDE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETODOLAC, FLUTICASONE PROPIONATE, HYDROXYCHLOROQUINE, LACOSAMIDE, LACOSAMIDE, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, PSYLLIUM HUSK, METHOCARBAMOL, METHOCARBAMOL TABLETS, OXYCODONE, PANTOPRAZOLE, PRIMIDONE, SIMVASTATIN, TOPIRAMATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, UBROGEPANT, ALBUTEROL SULFATE, EPINEPHRINE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 1593 | 26639679 |
US |
68 | 2 |
Rash erythematous, Pruritus, Skin burning sensation, Pain in extremity, Vision blurred, Dry throat, Gait disturbance, Lethargy, Arthralgia, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, FLUOCINONIDE, FLUOCINONIDE TOPICAL SOLUTION USP, 0.05%, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ALBUTEROL SULFATE, ACETYLCYSTEINE, ERGOCALCIFEROL, GUAIFENESIN, LOPERAMIDE HYDROCHLORIDE, LORATADINE, LORATADINE ORAL, LORAZEPAM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, |
||||
| 1594 | 26639687 |
US |
68 | 1 |
Pain, Activities of daily living decreased, Gait disturbance, |
||||
DUPILUMAB, |
||||
| 1595 | 26639896 |
US |
1 | |
Dehydration, Gait disturbance, Balance disorder, Vision blurred, Fall, Skin abrasion, Product dose omission issue, |
||||
OSIMERTINIB, |
||||
| 1596 | 26639926 |
JP |
47 | 1 |
Encephalitis, Cerebral atrophy, Multiple sclerosis relapse, Gait disturbance, Motor dysfunction, Cognitive disorder, |
||||
OFATUMUMAB, AZATHIOPRINE, |
||||
| 1597 | 26641893 |
24 | 2 | |
Gastrointestinal disorder, Abdominal pain upper, Gait disturbance, |
||||
LEVONORGESTREL, |
||||
| 1598 | 26643310 |
68 | 2 | |
Inflammation, Groin pain, Gait disturbance, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, PREDNISONE, VALSARTAN, VALSARTAN ORAL, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, FLUTICASONE PROPIONATE, BUDESONIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ERGOCALCIFEROL, CETIRIZINE HYDROCHLORIDE, |
||||
| 1599 | 26638584 |
76 | 2 | |
Hypersensitivity, Pharyngeal swelling, Illness, Asthenia, Fatigue, Abdominal discomfort, Gait disturbance, Cough, Weight decreased, Dizziness, |
||||
BUPROPION, DEXTROAMPHETAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE SODIUM SUCCINATE, |
||||
| 1600 | 26638588 |
US |
74 | 1 |
Intestinal haemorrhage, Depression, Haemoglobin decreased, Gait disturbance, Malaise, |
||||
TAFAMIDIS, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30
